The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance - PubMed (original) (raw)
The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance
R Hernandez-Pando et al. Immunology. 1994 Aug.
Abstract
The role of tumour necrosis factor-alpha (TNF-alpha) in tuberculosis is paradoxical because although there is much evidence for a protective role, there is also evidence that it plays a part in the tissue damage that characterizes human disease. We have shown previously that TNF-alpha frequently induces necrosis when injected into sites undergoing delayed-type hypersensitivity (DTH) responses to mycobacterial antigen. This is dependent on CD4+ T cells. However the presence of this sensitivity to TNF-alpha-induced necrosis depended on the immunization protocol. We have tested the hypothesis that sensitivity to TNF-alpha depends on the cytokine profile of the induced T-cell response. All subcutaneous doses of mycobacterial immunogen used (10(7) to 10(9) organisms) primed spleen cells so that they secreted interferon-gamma (IFN-gamma) and interleukin-2 (IL-2) when cultured in vitro with soluble antigen. However priming for production of IL-4 was dose dependent as in other systems, and was produced at all times from 7 to 30 days after immunization with 10(9) organisms. Time-course studies over 30 days showed that sensitivity to TNF-alpha was found in DTH sites of animals primed for IL-4 and IFN-gamma production, but not in animals primed only for the Th1 cytokines. We suggest therefore that the paradoxical role of TNF-alpha can be resolved. In 'pure' Th1 responses it may act as an additional macrophage-activating factor. In mixed Th1 + Th2 or Th0 responses it may cause tissue damage. This mixed pattern is characteristic of tuberculosis, and of the late stage of many chronic infections where elimination of the infecting organism is failing, and chronic tissue damage is seen.
Similar articles
- Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin.
Sander B, Skansén-Saphir U, Damm O, Håkansson L, Andersson J, Andersson U. Sander B, et al. Immunology. 1995 Dec;86(4):512-8. Immunology. 1995. PMID: 8567014 Free PMC article. - Generation, persistence, and modulation of Th0 effector cells: role of autocrine IL-4 and IFN-gamma.
Miner KT, Croft M. Miner KT, et al. J Immunol. 1998 Jun 1;160(11):5280-7. J Immunol. 1998. PMID: 9605125 - Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy.
Del Prete G. Del Prete G. Allergy. 1992 Oct;47(5):450-5. doi: 10.1111/j.1398-9995.1992.tb00662.x. Allergy. 1992. PMID: 1485646 Review. - [Cytokines in MS lesion].
Kato H, Suzumura A. Kato H, et al. Nihon Rinsho. 2003 Aug;61(8):1428-34. Nihon Rinsho. 2003. PMID: 12962034 Review. Japanese.
Cited by
- ESAT-6 Targeting to DEC205+ Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis.
Silva-Sánchez A, Meza-Pérez S, Flores-Langarica A, Donis-Maturano L, Estrada-García I, Calderón-Amador J, Hernández-Pando R, Idoyaga J, Steinman RM, Flores-Romo L. Silva-Sánchez A, et al. PLoS One. 2015 Apr 27;10(4):e0124828. doi: 10.1371/journal.pone.0124828. eCollection 2015. PLoS One. 2015. PMID: 25915045 Free PMC article. - Treatment with BB-94, a broad spectrum inhibitor of zinc-dependent metalloproteinases, causes deviation of the cytokine profile towards type-2 in experimental pulmonary tuberculosis in Balb/c mice.
Hernandez-Pando R, Orozco H, Arriaga K, Pavön L, Rook G. Hernandez-Pando R, et al. Int J Exp Pathol. 2000 Jun;81(3):199-209. doi: 10.1046/j.1365-2613.2000.00152.x. Int J Exp Pathol. 2000. PMID: 10971741 Free PMC article. - Activation of astrocytes and expression of inflammatory cytokines in rats with experimental autoimmune encephalomyelitis.
Zhang L, Xie H, Cui L. Zhang L, et al. Exp Ther Med. 2018 Dec;16(6):4401-4406. doi: 10.3892/etm.2018.6798. Epub 2018 Sep 27. Exp Ther Med. 2018. PMID: 30546391 Free PMC article. - Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts.
Zhu X, Liu Q, Wang M, Liang M, Yang X, Xu X, Zou H, Qiu J. Zhu X, et al. PLoS One. 2011;6(11):e27081. doi: 10.1371/journal.pone.0027081. Epub 2011 Nov 1. PLoS One. 2011. PMID: 22069489 Free PMC article. - Levamisole as an Adjuvant to Short-Course Therapy in Newly Diagnosed Pulmonary Tuberculosis Patients.
Shamkuwar CA, Meshram SH, Mahakalkar SM. Shamkuwar CA, et al. Adv Biomed Res. 2017 Mar 28;6:37. doi: 10.4103/2277-9175.203162. eCollection 2017. Adv Biomed Res. 2017. PMID: 28516071 Free PMC article.
References
- Am J Pathol. 1972 Apr;67(1):23-40 - PubMed
- Immunology. 1994 Feb;81(2):171-6 - PubMed
- J Exp Med. 1985 Aug 1;162(2):401-12 - PubMed
- Cell. 1989 Mar 10;56(5):731-40 - PubMed
- Br Med Bull. 1988 Jul;44(3):611-23 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials